Archived Facts

Posts Tagged ‘Myers’

Bristol-Myers Squibb Co. said Tuesday it finished buying out drug maker ZymoGenetics Inc. by means of a “short-form merger.”

Here is the original post:
Bristol-Myers closes ZymoGenetics buyout

Related Posts:

Mylan Inc. said Tuesday that it received tentative Food and Drug Administration approval for a generic version of Bristol-Myers Squibb Co.’s HIV drug Reyataz.

Read more:
Mylan gets FDA approval for generic Reyataz

Related Posts:

The drugmaker Bristol-Myers Squibb Co. said Tuesday the Hart-Scott-Rodino waiting period for its offer to buy biotechnology company ZymoGenetics Inc. has expired.

The rest is here:
Bristol-Myers says waiting period ends for deal

Related Posts:

Drugmaker Bristol-Myers Squibb Co. is cutting jobs again, this time eliminating about 3 percent of its positions in its latest effort to streamline operations.

View original post here:
Bristol-Myers to cut about 840 jobs worldwide

Related Posts:

Drugmaker Bristol-Myers Squibb Co. is cutting jobs again, this time eliminating about 3 percent of its positions in its latest effort to streamline operations.

See the article here:
Bristol-Myers to cut about 840 jobs worldwide

Related Posts:

Drugmaker Bristol-Myers Squibb Co. is cutting jobs again, this time eliminating about 3 percent of its positions in its latest effort to streamline operations.

Read more:
Bristol-Myers to cut about 840 jobs worldwide

Related Posts:

Drugmaker Bristol-Myers Squibb Co. is cutting jobs again, this time eliminating about 3 percent of its positions in its latest effort to streamline operations.

Continue reading here:
Bristol-Myers to cut about 840 jobs worldwide

Related Posts:

The U.S. Food and Drug Administration has warned drug giant Bristol-Myers Squibb Co. of possible sanctions if it fails to correct “significant violations” of good manufacturing practices at one of its two plants in Puerto Rico.

Go here to see the original:
FDA warns drugmaker about violations at PR plant

Related Posts:

Drugmaker Bristol-Myers Squibb Co. said Thursday its second-quarter sales were up slightly but profit was down nearly 6 percent, due to the loss of revenue from its former nutrition business, spun off late last year.

See the original post here:
Bristol-Myers posts 6 percent drop in 2Q profit

Related Posts:

Bristol-Myers Squibb Co. said Wednesday European regulators approved Orencia as an early treatment for rheumatoid arthritis.

Read this article:
Bristol-Myers’ Orencia gets expanded use in Europe

Related Posts: